DPP4 and pulmonary fibrosis: Soare et al. [64] recently found that pharmacological inhibition of DPP-4 promoted regression of bleomycin-induced dermal thickness in murine models of systemic sclerosis, and DPP4-knockout mice were less susceptible to bleomycin-induced dermal and pulmonary fibrosis.